The next 12 months are likely to see further major developments in gene-editing technologies, a field which attracted billions of dollars of funding in 2021, thanks to a range of novel and maturing platforms which have the potential to offer new treatments and possible cures for genetic diseases.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?